Inhibition of histone acetylation by curcumin reduces alcohol-induced expression of heart development-related transcription factors in cardiac progenitor cells

Biochemical and Biophysical Research Communications

Volumn 424, Issue 3, 2012, Pages 593-596

  Wang, Linyi ^a,b   Sun, Huichao ^a   Pan, Bo ^a,b   Zhu, Jing ^b   Huang, Guoying ^c   Huang, Xupei ^d   Tian, Jie ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^d FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Alcohol; Cardiac progenitor cells; Curcumin; Histone acetylation; Transcription factors

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALCOHOL; CURCUMIN; HISTONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR MEF2C; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG;

ARTICLE; CARDIAC PROGENITOR CELL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; GENE OVEREXPRESSION; HEART DEVELOPMENT; HEART MUSCLE CELL; HISTONE ACETYLATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETYLATION; ANIMALS; CELL LINE; CURCUMIN; ETHANOL; HEART; HEART DEFECTS, CONGENITAL; HISTONES; LYSINE; MICE; MYOBLASTS, CARDIAC; TRANSCRIPTION FACTORS;

EID: 84864751026     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.158     Document Type: Article

References (23)

1. Day N.L., Richardson G.A. An analysis of the effects of prenatal alcohol exposure on growth: a teratologic model. Am. J. Med. Genet. C Semin. Med. Genet. 2004, 127:28-34.
2. Webster W.S., Germain M.A. A Lipson, D Walsh, Alcohol and congenital heart defects: an experimental study in mice. Cardiovasc. Res. 1984, 18:335-338.
3. Julien I.E.H., Samuel K. The incidence of congenital heart disease. J. Am. Coil. Cardiol. 2002, 39:1890.
4. Backs J., Olson E.N. Control of cardiac growth by histone acetylation deacetylation. Circ. Res. 2006, 98:15-24.
5. Karamboulas C., Swedani A., Ward C. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. J. Cell. Sci. 2006, 119:4305-4314.
6. Yang X.J., Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. J. Mol. Cell 2008, 31:449-461.
7. Ott H.C., Matthiesen T.S., Goh S.K. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 2008, 14:213-221.
8. Haycock P.C. Fetal alcohol spectrum disorders: the epigenetic perspective. Biol. Reprod. 2009, 81:607-617.
9. Zhu J., Feng C., Li L., Deng B., Tian J. ShRNA on histone acetylation induces unusual cardiac-specific protein expression in MSCs differentiation into cardiomyocytes. Acta Acad. Med. Militaris Tertiae 2008, 30:303-306.
10. Zhu J., Deng B., Wang J., Tian J., Wang Y. Detection of cardiac development gene after RNA interference for histone acetylation to MSCs induced by 5-azacytidine. Acta Acad. Med. Militaris Tertiae 2006, 28:535-538.
11. Zhong L., Zhu J., Lv T. Ethanol and its metabolites induce Histone lysine 9 acetylation and an alteration of the expression of heart development-related genes in cardiac progenitor cells. Cardiovasc. Toxicol. 2010, 10:268-274.
12. Karanam B., Radhika A.V., Mohammed A. Curcumin, a novel p300/CREB-binding protein - specific inhibitor of acetyltransferase represses the acetylation of histone/nonhistone proteins and histone acetyl transferase - dependent chromatin transcription. J. Biol. Chem. 2004, 279:51163-51171.
13. Zhu G., Huang J., Bi Y. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 2009, 78:195-204.
14. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8:253-262.
15. Dolinoy D.C., Jirtle R.L. Environmental epigenomics in human health and disease. Environ. Mol. Mutagen. 2008, 49:4-8.
16. Sterner D.E., Berger S.L. Acetylation of histones and transcriptionrelated factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
17. Horsthemke B. Epimutations in human disease. Curr. Top. Microbiol. Immunol. 2006, 310:45-59.
18. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., Conway S., Fu J.D., Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
19. Gruber P.J. Cardiac development: new concepts. Clin. Perinatol. 2005, 32:845-855.
20. Choudhury M., Shukla S.D. Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyltransferase and histone deacetylase. Alcohol Clin. Exp. Res. 2008, 32:829-839.
21. Kim J.S., Shukla S.D. Histone H3 modifications in rat hepatic stellate cells by ethanol. Alcohol Alcohol. 2005, 40:367-372.
22. Morinobu A., Kanno Y., O'Shea J.J. Discrete roles for histone acetylation in human T helper cell-specific gene expression. J. Biol. Chem. 2004, 279:40640-40646.
23. Morimoto T., Sunagawa Y., Kawamura T., Takaya T., Wada H., Nagasawa A., Komeda M., Fujita M., Shimatsu A., Kita T., Hasegawa K. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 2008, 118:868-878.